
Company Number
08010751
Next Accounts
Dec 2025
Shareholders
chris thornton
university of exeter
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
lowin house tregolls road, truro, cornwall, TR1 2NA
Website
www.iscadiagnostics.comPomanda estimates the enterprise value of ISCA DIAGNOSTICS LTD at £282.1k based on a Turnover of £248.9k and 1.13x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ISCA DIAGNOSTICS LTD at £76.3k based on an EBITDA of £16.9k and a 4.52x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ISCA DIAGNOSTICS LTD at £122.3k based on Net Assets of £76.8k and 1.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Isca Diagnostics Ltd is a live company located in cornwall, TR1 2NA with a Companies House number of 08010751. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in March 2012, it's largest shareholder is chris thornton with a 41% stake. Isca Diagnostics Ltd is a established, micro sized company, Pomanda has estimated its turnover at £248.9k with low growth in recent years.
Pomanda's financial health check has awarded Isca Diagnostics Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 3 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
3 Weak
Size
annual sales of £248.9k, make it smaller than the average company (£3.7m)
- Isca Diagnostics Ltd
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (11.9%)
- Isca Diagnostics Ltd
11.9% - Industry AVG
Production
with a gross margin of 53.7%, this company has a comparable cost of product (53.7%)
- Isca Diagnostics Ltd
53.7% - Industry AVG
Profitability
an operating margin of 5.2% make it more profitable than the average company (-5.6%)
- Isca Diagnostics Ltd
-5.6% - Industry AVG
Employees
with 2 employees, this is below the industry average (46)
2 - Isca Diagnostics Ltd
46 - Industry AVG
Pay Structure
on an average salary of £77.1k, the company has an equivalent pay structure (£77.1k)
- Isca Diagnostics Ltd
£77.1k - Industry AVG
Efficiency
resulting in sales per employee of £124.5k, this is equally as efficient (£124.5k)
- Isca Diagnostics Ltd
£124.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Isca Diagnostics Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Isca Diagnostics Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Isca Diagnostics Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 170 weeks, this is more cash available to meet short term requirements (33 weeks)
170 weeks - Isca Diagnostics Ltd
33 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 15.2%, this is a lower level of debt than the average (51.3%)
15.2% - Isca Diagnostics Ltd
51.3% - Industry AVG
Isca Diagnostics Ltd's latest turnover from March 2024 is estimated at £248.9 thousand and the company has net assets of £76.8 thousand. According to their latest financial statements, Isca Diagnostics Ltd has 2 employees and maintains cash reserves of £33.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 3 | |||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 5,483 | 8,203 | 5,453 | 5,786 | ||||||||
Intangible Assets | 9,316 | 10,452 | 11,588 | 12,724 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | |
Investments & Other | ||||||||||||
Debtors (Due After 1 year) | ||||||||||||
Total Fixed Assets | 14,799 | 18,655 | 17,041 | 18,510 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | |
Stock & work in progress | ||||||||||||
Trade Debtors | 301 | 4,985 | 600 | 3,165 | 9,794 | 18,373 | 46 | |||||
Group Debtors | ||||||||||||
Misc Debtors | 42,619 | 44,030 | 25,200 | 25,374 | 26,806 | 9,996 | 1,627 | 831 | 991 | |||
Cash | 33,100 | 27,582 | 53,258 | 58,821 | 36,900 | 48,816 | 62,012 | 138,495 | 69,672 | 46,153 | 122,768 | |
misc current assets | ||||||||||||
total current assets | 75,719 | 71,913 | 83,443 | 84,195 | 64,306 | 61,977 | 63,639 | 139,326 | 70,663 | 55,947 | 141,141 | 46 |
total assets | 90,518 | 90,568 | 100,484 | 102,705 | 66,806 | 64,477 | 66,139 | 141,826 | 73,163 | 58,447 | 143,641 | 46 |
Bank overdraft | ||||||||||||
Bank loan | 2,395 | 3,203 | 3,203 | 2,609 | ||||||||
Trade Creditors | 1,443 | 1,302 | 126 | 60 | 60 | 30 | 30 | 40,098 | 127,083 | 270 | ||
Group/Directors Accounts | ||||||||||||
other short term finances | 15,000 | 15,000 | 15,000 | 15,000 | ||||||||
hp & lease commitments | ||||||||||||
other current liabilities | 7,712 | 12,913 | 16,558 | 21,800 | 2,187 | 2,131 | 25,169 | 107,378 | 56,215 | |||
total current liabilities | 10,107 | 17,559 | 21,063 | 24,409 | 17,313 | 17,191 | 40,229 | 122,408 | 56,245 | 40,098 | 127,083 | 270 |
loans | 3,657 | 6,549 | 9,701 | 13,891 | ||||||||
hp & lease commitments | ||||||||||||
Accruals and Deferred Income | ||||||||||||
other liabilities | ||||||||||||
provisions | ||||||||||||
total long term liabilities | 3,657 | 6,549 | 9,701 | 13,891 | ||||||||
total liabilities | 13,764 | 24,108 | 30,764 | 38,300 | 17,313 | 17,191 | 40,229 | 122,408 | 56,245 | 40,098 | 127,083 | 270 |
net assets | 76,754 | 66,460 | 69,720 | 64,405 | 49,493 | 47,286 | 25,910 | 19,418 | 16,918 | 18,349 | 16,558 | -224 |
total shareholders funds | 76,754 | 66,460 | 69,720 | 64,405 | 49,493 | 47,286 | 25,910 | 19,418 | 16,918 | 18,349 | 16,558 | -224 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | 2,720 | 2,222 | 1,726 | |||||||||
Amortisation | 1,136 | 1,136 | 1,136 | 1,136 | ||||||||
Tax | ||||||||||||
Stock | ||||||||||||
Debtors | -1,712 | 14,146 | 4,811 | -2,032 | 14,245 | 11,534 | 796 | -160 | -8,803 | -8,579 | 18,327 | 46 |
Creditors | -1,443 | 141 | 1,302 | -126 | 66 | 30 | -40,068 | -86,985 | 126,813 | 270 | ||
Accruals and Deferred Income | -5,201 | -3,645 | -5,242 | 19,613 | 56 | -23,038 | -82,209 | 51,163 | 56,215 | |||
Deferred Taxes & Provisions | ||||||||||||
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | ||||||||||||
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | -808 | 594 | 2,609 | |||||||||
Group/Directors Accounts | ||||||||||||
Other Short Term Loans | -15,000 | 15,000 | ||||||||||
Long term loans | -2,892 | -3,152 | -4,190 | 13,891 | ||||||||
Hire Purchase and Lease Commitments | ||||||||||||
other long term liabilities | ||||||||||||
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | 5,518 | -25,676 | -5,563 | 21,921 | -11,916 | -13,196 | -76,483 | 68,823 | 23,519 | -76,615 | 122,768 | |
overdraft | ||||||||||||
change in cash | 5,518 | -25,676 | -5,563 | 21,921 | -11,916 | -13,196 | -76,483 | 68,823 | 23,519 | -76,615 | 122,768 |
Perform a competitor analysis for isca diagnostics ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in TR1 area or any other competitors across 12 key performance metrics.
ISCA DIAGNOSTICS LTD group structure
Isca Diagnostics Ltd has no subsidiary companies.
Ultimate parent company
ISCA DIAGNOSTICS LTD
08010751
Isca Diagnostics Ltd currently has 3 directors. The longest serving directors include Dr Michael Snaith (Apr 2013) and Dr Chris Thornton (Apr 2013).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Michael Snaith | United Kingdom | 56 years | Apr 2013 | - | Director |
Dr Chris Thornton | United Kingdom | 59 years | Apr 2013 | - | Director |
Mr Shawn McDermott | England | 64 years | Feb 2015 | - | Director |
P&L
March 2024turnover
248.9k
+347%
operating profit
13k
0%
gross margin
53.8%
+0.37%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
76.8k
+0.15%
total assets
90.5k
0%
cash
33.1k
+0.2%
net assets
Total assets minus all liabilities
company number
08010751
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
March 2012
age
13
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
lowin house tregolls road, truro, cornwall, TR1 2NA
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to isca diagnostics ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ISCA DIAGNOSTICS LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|